Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL121 (Avandamet, Avandaryl, Avandia, BRL-49653, Gaudil, NSC-758698, Rezult, Rosiglitazone, Rosiglizole, Rosvel, TDZ-01) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Sodium/bile acid and sulphated solute cotransporter 1/Bile acid transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5287] [GtoPdb: 959] [UniProtKB: Q14973] | ||||||||
ChEMBL | Inhibition of HA-tagged human NTCP expressed in human U2OS cells assessed as reduction in [14C]taurocholate uptake preincubated for 10 mins followed by [14C] taurocholate addition and further incubation for 10 mins by scintillation counting method | B | 5.29 | pIC50 | 5100 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 126623-126623 [PMID:31439379] |
ABCB11/Bile salt export pump in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6020] [GtoPdb: 778] [UniProtKB: O95342] | ||||||||
ChEMBL | Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake | B | 5.19 | pIC50 | 6400 | nM | IC50 | Drug Metab Dispos (2012) 40: 130-138 [PMID:21965623] |
ABCB11/Bile salt export pump in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073674] [GtoPdb: 778] [UniProtKB: O70127] | ||||||||
ChEMBL | Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake | B | 4.4 | pIC50 | 40000 | nM | IC50 | Drug Metab Dispos (2012) 40: 130-138 [PMID:21965623] |
carbonic anhydrase 2/Carbonic anhydrase II in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL205] [GtoPdb: 3092] [UniProtKB: P00918] | ||||||||
ChEMBL | DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)) | B | 5.39 | pIC50 | 4069 | nM | IC50 | DrugMatrix in vitro pharmacology data |
carnitine palmitoyltransferase 1A/Carnitine O-palmitoyltransferase 1, liver isoform in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293194] [GtoPdb: 3249] [UniProtKB: P50416] | ||||||||
ChEMBL | SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 1, liver isoform | B | 5 | pIC50 | >10000 | nM | IC50 | Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752). |
carnitine palmitoyltransferase 1B/Carnitine O-palmitoyltransferase 1, muscle isoform in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2216739] [GtoPdb: 3250] [UniProtKB: Q92523] | ||||||||
ChEMBL | SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 1, muscle isoform | B | 4 | pIC50 | >100000 | nM | IC50 | Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752). |
carnitine palmitoyltransferase 2/Carnitine palmitoyltransferase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3238] [GtoPdb: 3252] [UniProtKB: P23786] | ||||||||
ChEMBL | SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 2 | B | 4 | pIC50 | >100000 | nM | IC50 | Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752). |
carnitine palmitoyltransferase 2/Carnitine palmitoyltransferase 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4037] [GtoPdb: 3252] [UniProtKB: P18886] | ||||||||
ChEMBL | SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 2 | B | 4 | pIC50 | >100000 | nM | IC50 | Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752). |
CDGSH iron-sulfur domain-containing protein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1795168] [UniProtKB: Q9NZ45] | ||||||||
ChEMBL | Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by Cheng-Prusoff analysis | B | 7.51 | pKi | 31 | nM | Ki | Bioorg Med Chem Lett (2016) 26: 5350-5353 [PMID:27687671] |
ChEMBL | Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by scintillation proximity assay | B | 6.14 | pIC50 | 731 | nM | IC50 | Bioorg Med Chem Lett (2016) 26: 5350-5353 [PMID:27687671] |
CDGSH iron-sulfur domain-containing protein 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3308979] [UniProtKB: B0K020] | ||||||||
ChEMBL | Displacement of [3H]rosiglitazone from rat liver mitochondrial mitoNEET by scintillation counting | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 819-823 [PMID:20064719] |
CDGSH iron-sulfur domain-containing protein 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4523399] [UniProtKB: Q8N5K1] | ||||||||
ChEMBL | Binding affinity to recombinant human N-terminal His6-tagged NAF1 expressed in Escherichia coli by scintillation proximity assay | B | 5.64 | pIC50 | 2290 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 901-904 [PMID:30770154] |
FFA1 receptor/Free fatty acid receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4422] [GtoPdb: 225] [UniProtKB: O14842] | ||||||||
ChEMBL | Agonist activity at FFAR1 (unknown origin) assessed as increase in ERK1/2 MAP kinase phosphorylation | B | 4.94 | pEC50 | 11481.54 | nM | EC50 | Bioorg Med Chem Lett (2014) 24: 5330-5336 [PMID:25441945] |
GtoPdb | - | - | 5.6 | pEC50 | - | - | - | Biochem Biophys Res Commun (2003) 301: 406-10 [PMID:12565875] |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG expressed in CHO cells by patch clamp assay | B | 4.53 | pIC50 | 29500 | nM | IC50 | Eur J Med Chem (2019) 162: 650-665 [PMID:30481687] |
Monoamine oxidase A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1951] [GtoPdb: 2489] [UniProtKB: P21397] | ||||||||
ChEMBL | Competitive inhibition of human MAOA expressed in Pichia pastoris | B | 4.56 | pKi | 27600 | nM | Ki | ACS Med Chem Lett (2012) 3: 39-42 [PMID:22282722] |
Monoamine oxidase A in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3358] [UniProtKB: P21396] | ||||||||
ChEMBL | Competitive inhibition of rat MAOA expressed in Pichia pastoris | B | 4.49 | pKi | 32600 | nM | Ki | ACS Med Chem Lett (2012) 3: 39-42 [PMID:22282722] |
Monoamine oxidase B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2039] [GtoPdb: 2490] [UniProtKB: P27338] | ||||||||
ChEMBL | Competitive inhibition of human MAOB expressed in Pichia pastoris | B | 5.38 | pKi | 4200 | nM | Ki | ACS Med Chem Lett (2012) 3: 39-42 [PMID:22282722] |
ChEMBL | Inhibition of human recombinant MAO-B after 15 mins | B | 6.08 | pIC50 | 832 | nM | IC50 | Bioorg Med Chem Lett (2010) 20: 5295-5298 [PMID:20650633] |
ChEMBL | Inhibition of recombinant human MAO-B | B | 6.08 | pIC50 | 832 | nM | IC50 | Bioorg Med Chem Lett (2022) 76: 128994-128994 [PMID:36162779] |
Monoamine oxidase B in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2993] [GtoPdb: 2490] [UniProtKB: P19643] | ||||||||
ChEMBL | Competitive inhibition of rat MAOB expressed in Pichia pastoris | B | 5.24 | pKi | 5800 | nM | Ki | ACS Med Chem Lett (2012) 3: 39-42 [PMID:22282722] |
Peroxisome proliferator-activated receptor-α/Peroxisome proliferator-activated receptor alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL239] [GtoPdb: 593] [UniProtKB: Q07869] | ||||||||
ChEMBL | In vitro binding affinity towards human peroxisome proliferator activated receptor alpha (PPAR alpha) | B | 4.48 | pKi | >33300 | nM | Ki | Bioorg Med Chem Lett (2003) 13: 931-935 [PMID:12617924] |
ChEMBL | Inhibition of human Peroxisome proliferator activated receptor alpha | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2005) 48: 2248-2250 [PMID:15771468] |
ChEMBL | Inhibition of human Peroxisome proliferator activated receptor alpha binding | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2005) 48: 2262-2265 [PMID:15801817] |
ChEMBL | In vitro binding affinity against human PPAR alpha (peroxisome proliferator-activated alpha receptor) | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1801-1804 [PMID:12729668] |
ChEMBL | In vitro binding affinity against human Peroxisome proliferator activated receptor alpha | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2795-2798 [PMID:12873517] |
ChEMBL | Inhibition of human PPARalpha receptor by scintillation proximity assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2009) 52: 4443-4453 [PMID:19530681] |
ChEMBL | Displacement of [3H2]nTZD3 from human recombinant GST-fused PPARalpha expressed in Escherichia coli by scintillation proximity assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2009) 52: 3846-3854 [PMID:19507861] |
ChEMBL | Displacement of [3H2]nTZD3 from GST-tagged human recombinant PPARalpha by scintillation proximity assay | B | 4.82 | pIC50 | >15000 | nM | IC50 | J Med Chem (2009) 52: 4631-4639 [PMID:19719236] |
ChEMBL | In vitro binding affinity for human peroxisome proliferator activated receptor alpha using scintillation proximity assay (SPA) | B | 4.82 | pIC50 | >15000 | nM | IC50 | J Med Chem (2004) 47: 3255-3263 [PMID:15163205] |
ChEMBL | Inhibition of PPARalpha | B | 4.82 | pIC50 | >15000 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 1939-1944 [PMID:18291645] |
ChEMBL | Mean inhibitory concentration against human peroxisome proliferator activated receptor alpha | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2005) 15: 51-55 [PMID:15582409] |
ChEMBL | Displacement of tritium labeled ligand from human PPARalpha by SPA assay | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 6293-6297 [PMID:17005393] |
ChEMBL | Displacement of [3H]2-(4-{2-[3-(2,4-difluoro-phenyl)-1-heptyl-ureido]-ethyl}-phenoxy)-2-methyl-butyric acid from hPPARalpha | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2006) 16: 6328-6333 [PMID:17005394] |
ChEMBL | Displacement of [3H]2-(4-{2-[3-(2,4-difluoro-phenyl)-1-heptyl-ureido]-ethyl}-phenoxy)-2-methyl-butyric acid from human PPARalpha | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 6744-6749 [PMID:18029178] |
ChEMBL | Receptor binding affinity to human Peroxisome proliferator activated receptor alpha against [3H]-NNC 0061-4655 radioligand | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2003) 46: 1306-1317 [PMID:12672231] |
ChEMBL | Displacement of radio labeled 2(S)-(2-benzoyl-phenylamino)-3-{4-[1,1-ditritio-2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid from GST-fused human PPARalpha expressed in Escherichia coli BL21 cells | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 2468-2473 [PMID:19349176] |
ChEMBL | Displacement of [3H]L-783483 from human PPAR alpha by SPA assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2006) 49: 1212-1216 [PMID:16451087] |
ChEMBL | Binding affinity towards human peroxidase proliferator activated receptor alpha (hPPARalpha) | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2001) 44: 2061-2064 [PMID:11405642] |
ChEMBL | In vitro binding affinity for human PPAR alpha in SPA | B | 8.3 | pIC50 | >5 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1277-1280 [PMID:12657263] |
ChEMBL | Effective concentration against human Peroxisome proliferator activated receptor alpha | B | 4.49 | pEC50 | >32000 | nM | EC50 | J Med Chem (2005) 48: 2248-2250 [PMID:15771468] |
ChEMBL | Agonist activity at human PPARalpha expressed in HepG2 cells by GAL4 transactivation assay | F | 4.92 | pEC50 | >12000 | nM | EC50 | Bioorg Med Chem (2009) 17: 7113-7125 [PMID:19783444] |
ChEMBL | Agonist activity at human PPARalpha expressed in HepG2 cells by GAL4 transactivation assay | F | 4.92 | pEC50 | >12000 | nM | EC50 | Bioorg Med Chem (2008) 16: 4883-4907 [PMID:18394907] |
ChEMBL | Agonist activity at human GAL4-tagged PPARalpha chimeric receptor expressed in HEK cells by transactivation assay | F | 4.98 | pEC50 | 10580 | nM | EC50 | Bioorg Med Chem Lett (2010) 20: 2605-2608 [PMID:20299214] |
ChEMBL | Effective concentration against human Peroxisome proliferator activated receptor alpha in Gal4 transactivation assay | B | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2005) 48: 2262-2265 [PMID:15801817] |
ChEMBL | Agonist activity at human PPARalpha by luciferase reporter transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 2468-2473 [PMID:19349176] |
ChEMBL | Transactivation of human Gal4-fused PPARalpha LBD expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay | B | 5 | pEC50 | 10000 | nM | EC50 | Eur J Med Chem (2017) 137: 310-326 [PMID:28609708] |
ChEMBL | Agonist activity at human PPARalpha-LBD expressed in CV1 cells co-transfected with Gal4 after 40 hrs by luciferase based transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem (2011) 19: 3255-3264 [PMID:21515063] |
ChEMBL | Transactivation of Gal4-fused human PPARalpha DNA binding domain expressed in african green monkey CV1 cells by luciferase reporter gene assay | B | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 240-244 [PMID:21112784] |
ChEMBL | Agonist activity at human PPAR alpha in a HepG2 cells by PPAR-GAL4 transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 6120-6123 [PMID:16973358] |
ChEMBL | Agonist activity at human PPAR alpha in HepG2 cells by PPAR-GAL4 transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 6116-6119 [PMID:16979341] |
ChEMBL | Activity at human liver PPAR alpha expressed in HEK293 cells by PPAR-GAL4 transactivation assay | B | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2007) 50: 1495-1503 [PMID:17343371] |
ChEMBL | Agonist activity at human PPARalpha by transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 4144-4149 [PMID:17553681] |
ChEMBL | Agonist activity at human PPARalpha by transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 4625-4629 [PMID:17560785] |
ChEMBL | Agonist activity at human PPARalpha by GAL4 transactivation assay | F | 5 | pEC50 | 10000 | nM | EC50 | Bioorg Med Chem Lett (2008) 18: 1617-1622 [PMID:18255290] |
ChEMBL | Agonist activity at human recombinant PPARalpha LBD expressed in african green monkey COS7 cells coexpressing GAL4 by luciferase reporter gene transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2010) 20: 1581-1584 [PMID:20138762] |
ChEMBL | Agonist activity at human PPARalpha receptor by cell based transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2009) 52: 2618-2622 [PMID:19301897] |
ChEMBL | Agonist activity at PPARalpha ligand binding domain expressed in human HeLa cells co-transfected with Gal4-DBD assessed as transcriptional activation by Gal4 response element-driven luciferase reporter gene assay | B | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 1883-1886 [PMID:19275963] |
ChEMBL | In vitro effective concentration against human peroxisome proliferator activated receptor alpha/Gal4 in transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2005) 15: 4421-4426 [PMID:16137885] |
ChEMBL | Agonist activity at PPARalpha in HEK293 cells by GAL4 transactivation assay | F | 5.3 | pEC50 | >5000 | nM | EC50 | Bioorg Med Chem Lett (2008) 18: 1939-1944 [PMID:18291645] |
ChEMBL | Agonist activity at human PPARalpha by transactivation assay | F | 5.39 | pEC50 | 4100 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 3198-3202 [PMID:17379517] |
ChEMBL | In vitro activation of human peroxisome proliferator activated receptor alpha | B | 5.39 | pEC50 | 4100 | nM | EC50 | Bioorg Med Chem Lett (2003) 13: 257-260 [PMID:12482434] |
ChEMBL | In vitro transactivation using receptor transactivation assay against hPPAR alpha | F | 5.39 | pEC50 | 4100 | nM | EC50 | J Med Chem (2002) 45: 789-804 [PMID:11831892] |
ChEMBL | Effective concentration for human peroxisome proliferator-activated receptor alpha | B | 5.39 | pEC50 | 4100 | nM | EC50 | Bioorg Med Chem Lett (2005) 15: 1497-1500 [PMID:15713415] |
ChEMBL | In vitro transactivation of human Peroxisome proliferator activated receptor alpha (hPPARalpha) | B | 5.39 | pEC50 | 4100 | nM | EC50 | J Med Chem (2003) 46: 4883-4894 [PMID:14584939] |
ChEMBL | Agonist activity at human PPARalpha ligand binding domain expressed in african green monkey CV1 cells co-transfected with fused Gal4-DBD by transactivation assay | B | 5.46 | pEC50 | 3460 | nM | EC50 | J Med Chem (2008) 51: 6318-6333 [PMID:18826205] |
ChEMBL | Agonist activity at human PPARalpha expressed in african green monkey CV-1 by co-transfected with GAL4 by by dual-glo luciferase reporter gene assay | F | 5.46 | pEC50 | 3460 | nM | EC50 | Bioorg Med Chem Lett (2008) 18: 4993-4996 [PMID:18771917] |
ChEMBL | Agonist activity at human PPARalpha in CV1 cells by GAL4 transactivation assay after 24 hrs | F | 5.46 | pEC50 | 3460 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 3595-3598 [PMID:17507225] |
ChEMBL | Agonist activity at human PPARalpha transfected in COS-7 cells assessed luciferase activity measured after 24 hrs by cell based luciferase transactivation assay | B | 5.47 | pEC50 | 3390 | nM | EC50 | J Med Chem (2021) 64: 6996-7032 [PMID:33988379] |
ChEMBL | Agonist activity at human PPARalpha receptor expressed in african green monkey COS1 cells co-transfected with fused yeast Gal4-DBD by transactivation assay | F | 5.52 | pEC50 | >3000 | nM | EC50 | J Med Chem (2009) 52: 4443-4453 [PMID:19530681] |
ChEMBL | Displacement of radiolabeled GW-2331 from human PPAR alpha by SPA binding assay | B | 5.52 | pEC50 | 3000 | nM | EC50 | Bioorg Med Chem Lett (2006) 16: 6120-6123 [PMID:16973358] |
ChEMBL | In vitro agonist activity tested for transactivation in human PPAR alpha-Gal4 chimeric COS-1 cells | F | 5.52 | pEC50 | >3000 | nM | EC50 | Bioorg Med Chem Lett (2003) 13: 1801-1804 [PMID:12729668] |
ChEMBL | In vitro transactivation of human Peroxisome proliferator activated receptor alpha measured in PPAR-GAL4 chimeric COS-1 cell | F | 5.52 | pEC50 | >3000 | nM | EC50 | Bioorg Med Chem Lett (2003) 13: 2795-2798 [PMID:12873517] |
ChEMBL | Agonist activity at human PPARalpha ligand binding domain expressed in COS-1 cells co-transfected with Gal4 after 24 hrs by luciferase reporter gene assay | B | 6 | pEC50 | >1000 | nM | EC50 | Bioorg Med Chem (2011) 19: 6982-6988 [PMID:22051054] |
ChEMBL | Transactivation of N-terminal Gal4 DNA binding domain-linked human PPARalpha ligand binding domain after 24 hrs by luciferase reporter gene assay relative to vehicle-treated control | B | 6.62 | pEC50 | 240 | nM | EC50 | Eur J Med Chem (2016) 109: 157-172 [PMID:26774923] |
ChEMBL | Effective concentration for human peroxisome proliferator-activated receptor gamma | B | 6.7 | pEC50 | 200 | nM | EC50 | Bioorg Med Chem Lett (2005) 15: 1497-1500 [PMID:15713415] |
ChEMBL | In vitro transcription activation on human peroxisome proliferator activated receptor-alpha (PPAR alpha) | B | 6.85 | pEC50 | 140 | nM | EC50 | Bioorg Med Chem Lett (2004) 14: 3507-3511 [PMID:15177462] |
ChEMBL | Agonist activity at human PPARalpha ligand binding domain expressed in human HepG2 cells co-transfected with Gal4 by luciferase reporter gene assay | B | 7.41 | pEC50 | 39 | nM | EC50 | Bioorg Med Chem (2008) 16: 9498-9510 [PMID:18835719] |
ChEMBL | Agonist activity at human PPARalpha at 100 uM by GAL4 transactivation assay relative to WY 14,643 | F | 8.4 | pEC50 | 4 | nM | EC50 | Bioorg Med Chem Lett (2008) 18: 1617-1622 [PMID:18255290] |
Peroxisome proliferator-activated receptor-α/Peroxisome proliferator-activated receptor alpha in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2128] [GtoPdb: 593] [UniProtKB: P23204] | ||||||||
ChEMBL | Activation of mouse liver PPARalpha | B | 7.1 | pIC50 | 80 | nM | IC50 | J Med Chem (2020) 63: 5031-5073 [PMID:31930920] |
ChEMBL | Agonist activity at mouse PPARalpha receptor expressed in african green monkey COS1 cells co-transfected with fused yeast Gal4-DBD by transactivation assay | F | 5.52 | pEC50 | >3000 | nM | EC50 | J Med Chem (2009) 52: 4443-4453 [PMID:19530681] |
Peroxisome proliferator-activated receptor-β/δ/Peroxisome proliferator-activated receptor delta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3979] [GtoPdb: 594] [UniProtKB: Q03181] | ||||||||
ChEMBL | In vitro binding affinity towards human peroxisome proliferator activated receptor delta (PPAR delta) | B | 4.48 | pKi | >33300 | nM | Ki | Bioorg Med Chem Lett (2003) 13: 931-935 [PMID:12617924] |
ChEMBL | In vitro binding affinity against human Peroxisome proliferator activated receptor delta | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 2795-2798 [PMID:12873517] |
ChEMBL | In vitro binding affinity against human PPAR delta (peroxisome proliferator-activated delta receptor) | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1801-1804 [PMID:12729668] |
ChEMBL | In vitro binding affinity for human Peroxisome proliferator activated receptor gamma using scintillation proximity assay (SPA) | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2004) 47: 3255-3263 [PMID:15163205] |
ChEMBL | Displacement of [3H]2-(4-{2-[3-(2,4-difluoro-phenyl)-1-heptyl-ureido]-ethyl}-phenoxy)-2-methyl-butyric acid from human PPARdelta | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2007) 17: 6744-6749 [PMID:18029178] |
ChEMBL | In vitro binding affinity for human PPAR delta in SPA | B | 8.3 | pIC50 | >5 | nM | IC50 | Bioorg Med Chem Lett (2003) 13: 1277-1280 [PMID:12657263] |
ChEMBL | Agonist activity at PPARdelta ligand binding domain expressed in human HeLa cells co-transfected with Gal4-DBD assessed as transcriptional activation by Gal4 response element-driven luciferase reporter gene assay | B | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2009) 19: 1883-1886 [PMID:19275963] |
ChEMBL | Agonist activity at human PPARdelta-LBD expressed in CV1 cells co-transfected with Gal4 after 40 hrs by luciferase based transactivation assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem (2011) 19: 3255-3264 [PMID:21515063] |
ChEMBL | Transactivation of Gal4-fused human PPARdelta DNA binding domain expressed in african green monkey CV1 cells by luciferase reporter gene assay | B | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2011) 21: 240-244 [PMID:21112784] |
ChEMBL | Agonist activity at human PPARdelta receptor by cell based transactivation assay | F | 5 |